FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review

Radiotherapy and Oncology

Volumn 85, Issue 3, 2007, Pages 327-335

  Liu, Tao ^a   Xu, Wen ^b   Yan, Wei Li ^a   Ye, Ming ^a   Bai, Yong Rui ^a   Huang, Gang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

CT; MRI; PET; Residual or recurrent nasopharyngeal carcinoma; Systematic review

Indexed keywords

FLUORODEOXYGLUCOSE;

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; EMBASE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MEDLINE; MINIMAL RESIDUAL DISEASE; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; TUMOR RECURRENCE;

FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36749046293     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.11.002     Document Type: Review

References (47)

1. Marks J.E., Phillips J.L., and Menck H.R. The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 83 (1998) 582-588
2. Chang E.T., and Adami H.O. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prevent 15 (2006) 1765-1777
3. Fountzilas G., Tolis C., Kalogera F.A., et al. Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma. A Hellenic Cooperative Oncology Group phase II study. Strahlenther Onkol 181 (2005) 223-230
4. Kim Y.I., Han M.H., Cha S.H., et al. Nasopharyngeal carcinoma: posttreatment changes of imaging findings. Am J Otolaryngol 24 (2003) 224-230
5. Jeyakumar A., Brickman T.M., Jeyakumar A., et al. Review of nasopharyngeal carcinoma. ENT Ear Nose Throat J 85 (2006) 168-173
6. Guigay J., Temam S., Bourhis J., et al. Nasopharyngeal carcinoma and therapeutic management: the place of chemotherapy. Ann Oncol 17 (2006) 304-307
7. Vokes E.E., Weichselbaum R.R., Lippman S.M., et al. Head and neck cancer. N Engl J Med 328 (1993) 184-194
8. Chang J.T., See L.C., Liao C.T., et al. Locally recurrent nasopharyngeal carcinoma. Radiother Oncol 54 (2000) 135-142
9. Rosenblatt E., Brook O.R., Erlich N., et al. Late visual and auditory toxicity of radiotherapy for nasopharyngeal carcinoma. Tumori 89 (2003) 68-74
10. King A.D., Ahuja A.T., Yeung D.K., et al. Delayed complications of radiotherapy treatment for nasopharyngeal carcinoma: imaging findings. Clin Radiol 62 (2007) 195-203
11. Shu C.H., Cheng H., Lirng J.F., et al. Salvage surgery for recurrent nasopharyngeal carcinoma. Laryngoscopy 110 (2000) 1483-1488
12. Sham J.S.T., Wei W.I., Kwan W.H., et al. Nasopharyngeal carcinoma: pattern of tumor regression after radiotherapy. Cancer 65 (1990) 216-220
13. Wu H.B., Wang Q.S., Wang M.F., et al. The imaging manifestation and clinical value of PET/CT in nasopharyngeal carcinoma. Chin J Nucl Med (Zhong Hua He Yi Xue Za Zhi) 25 (2005) 347-349
14. Chen Y.R., Gu M.X., and Li W.X. Detection of residue of nasopharyngeal carcinoma with FDG PET. Chin J Cancer (Ai Zheng) 21 (2002) 651-653
15. Jiang S.X., Mao M.W., and Zhao J.N. CT and MRI diagnosis of local recurrences or residues after radiotherapy of nasopharyngeal carcinoma. JPMI (Shi Yong Yi Xue Ying Xiang Zha Zhi) 1 (2000) 30-32
16. Kao C.H., ChangLai S.P., Chieng P.U., et al. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 16 (1998) 3550-3555
17. Yen R.F., Hung R.L., Pan M.H., et al. 18-Fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging. Cancer 98 (2003) 283-287
18. Chan S.C., Ng S.H., Chang J.T.C., et al. Advantages and pitfalls of 18F-fluoro-2-deoxy-d-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging. Eur J Nucl Med Mol Imaging 33 (2006) 1032-1040
19. Ng S.H., Joseph C.T.C., Chan S.C., et al. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. J Nucl Med 45 (2004) 1669-1676
20. Wu D.H., and Chen L.H. Clinical value of 18F-fluoro-2-deoxy-d-glucose positron emission tomography in detecting recurrent nasopharyngeal carcinoma at the parapharyngeal space after radiotherapy. J First Mil Med Univ (Di Yi Jun Yi Xue Bao) 23 (2003) 159-161
21. Van Houwelingen H.C., Zwinderman K.H., and Stijnen T. A bivariate approach to meta-analysis. Stat Med 12 (1993) 2273-2284
22. Van Houwelingen H.C., Arends L.R., and Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21 (2002) 589-624
23. Deville W.L., Bezemer P.D., and Bouter L.M. Publications on diagnostic test evaluation in family medicine journals: an optimal search strategy. J Clin Epidemiol 53 (2000) 65-69
24. Berlin J.A. Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group. Lancet 350 (1997) 185-186
25. Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25. Available from: http://www.biomedcentral.com/1471-2288/3/25 [accessed 10.11.2003].
26. Zamora J., Abraira V., Muriel A., et al. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6 (2006) 31
27. Littenberg B., and Moses L.E. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making 13 (1993) 313-321
28. Peng N.J., Yen S.H., Liu W.S., et al. Evaluation of the effect of radiation therapy to nasopharyngeal carcinoma by positron emission tomography with 2-[F-18]fluoro-2-deoxy-d-glucose. Clin Positron Imaging 3 (2000) 51-56 [abstract]
29. Luo Y.W., Ma D., Tang A.W., et al. The diagnosis value of FDG-PET in residual or recurrent nasopharyngeal carcinoma post-radiotherapy. Guangdong Med J (Guang Dong Yi Xue Za Zhi) 16 (2005) 1228-1230
30. Yen R.F., Hong R.L., Tzen K.Y., et al. Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma. J Nucl Med 46 (2005) 770-774
31. Tsai M.H., Shiau Y.C., Kao C.H., et al. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy. Cancer Res Clin Oncol 128 (2002) 279-282
32. Ma X.J., Lu J.J., Loh K.S., et al. Role of computed tomography imaging in predicting response of nasopharyngeal carcinoma to definitive radiation therapy. Laryngoscope 116 (2006) 2162-2165
33. Chong V.F.H., and Fan Y.F. Detection of recurrent nasopharyngeal carcinoma: MRI versus CT. Radiology 202 (1997) 463-470
34. Chao S.S., Loh K.S., and Tan L.K.S. Modalities of surveillance in treated nasopharyngeal. Otolaryngol Head Neck Surg 129 (2003) 61-64
35. 99mTc-MIBI SPECT imaging in the follow up observation of nasopharyngeal carcinoma. Radiol Practice (Fang She Xue Shi Jian ) 21 (2006) 1007-1109
36. Wu D.C., Deng B., and Long S.L. Value of nuclein tumorafin imaging and CT on diagnosis of recurrent nasopharyngeal carcinoma after radiotherapy. Appl J General Practice (Shi Yong Quan Ke Yi Xue) 4 (2006) 724-725
37. Wu C.F., Deng B., Long S.L., et al. The value of nuclein tumorafin imaging, computed tomography and magnetic resonance imaging in the diagnosis of recurrent nasopharyngeal carcinoma after radiotherapy. J Chin Phys (Zhong Guo Yi Shi Za Zhi) 8 (2006) 768-770
38. Wang Q. The clinical value of CT scan after radiotherapy of nasopharyngeal carcinoma. J Auris Nasus, Larynx (Er Bi Hou Xue Bao) 12 (1998) 180
39. Kostakoglu L., Uysal U., Özyar E., et al. Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma. J Nucl Med 38 (1997) 1009-1014
40. Kostakoglu L., Uysal U., Özyar E., et al. A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma. Eur J Nucl Med 24 (1997) 621-628
41. Lijmer J.G., Mol B.W., Heisterkamp S., et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 282 (1999) 1061-1066
42. Rutter C.M., and Gatsonis C.A. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20 (2001) 2865-2884
43. Pham B., Platt R., McAuley L., et al. Is there a "best way to detect and minimize publication bias? An empirical evaluation. Eval Health Prof 24 (2001) 109-125
44. Bossuyt P.M., Reitsma J.B., Bruns D.E., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Radiology 226 (2003) 24-28
45. Liang K.Y., and Zeger S.L. Regression analysis for correlated data. Annu Rev Public Health 14 (1993) 43-68
46. Greven K.M., Williams III D.W., Keyes Jr. J.W., et al. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer. Int J Radiat Oncol. 29 (1994) 841-845
47. Greven K.M., Williams III D.W., Keyes Jr. J.W., et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 74 (1994) 1355-1359